The impairment of the endothelium-dependent vascular dilation triggered by abnormal levels of nitric oxide (NO) and aberrant activity of the endothelial nitric oxide synthase (eNOS) are known factors associated with an increased incidence of stroke amongst Fabry patients [4]. This evidence concerns the gene NOS3 and stroke disorder.